Cash flow Organigram Global Inc.

Stocks

OGI

CA68617J1003

Healthcare Facilities & Services

Delayed Toronto S.E. Other stock markets 10:55:14 2026-06-11 EDT			5-day change	1st Jan Change
1.475 ^CAD	-0.34%		-2.32%	-36.15%

05-12	Organigram Global Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2026	CI
05-12	Organigram Global Inc. Updates Revenue Guidance for the Fiscal Year 2026	CI

f6c.Yrfy47QRL3zHROmKmtp2T-L5n5nmVJhOe70t-CuoU-8.CdG3m_hDQBivPYfr4-IpOpeM-azWPtEbKc5mvFvvOLsy1MSJ0VZATZcsjg

Published financial data: ORGANIGRAM GLOBAL INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: September	2021	2022	2023	2024	2025
Revenues	79.16M	146M	149M	160M	259M
Total Revenues	79.16M	146M	149M	160M	259M
Cost of Goods Sold, Total	108M	114M	114M	112M	169M
Gross Profit	-28.4M	31.57M	35.07M	47.52M	90.22M
Selling General & Admin Expenses, Total	52.59M	64.51M	71.68M	65.72M	90.6M
Stock-Based Compensation (IS)	-	-	-	6.27M	3.98M
R&D Expenses	-	5.96M	12.19M	11.2M	10.94M
Other Operating Expenses, Total	52.59M	70.48M	83.86M	83.2M	106M
Operating Income	-80.99M	-38.91M	-48.79M	-35.67M	-15.3M
Interest Expense, Total	-2.96M	-429K	-278K	-	-
Interest And Investment Income	854K	1.49M	3.69M	3.31M	1.15M
Net Interest Expenses	-2.11M	1.06M	3.41M	3.31M	1.15M
Income (Loss) On Equity Invest.	-1.12M	-1.36M	-927K	-5.28M	-
Other Non Operating Income (Expenses)	-803K	32.65M	4.04M	-8.48M	-28K
EBT, Excl. Unusual Items	-85.01M	-6.56M	-42.27M	-46.12M	-14.18M
Restructuring Charges	-	-	-	-	-
Merger & Related Restructuring Charges	-	-	-	-	-6.58M
Impairment of Goodwill	-	-	-38.75M	-	-
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-2.43M	-6.58M	-386K	633K	-9K
Asset Writedown	-10.83M	-4.24M	-155M	-	-
Insurance Settlements	-	181K	197K	-	-
Legal Settlements	-2.75M	310K	69.23K	-	-
Other Unusual Items	-29.68M	2.52M	3.35M	50K	-17.76M
EBT, Incl. Unusual Items	-131M	-14.37M	-233M	-45.44M	-38.53M
Income Tax Expense	-	-88K	-3.52M	-	-13.77M
Earnings From Continuing Operations	-131M	-14.28M	-229M	-45.44M	-24.76M
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	-131M	-14.28M	-229M	-45.44M	-24.76M
Net Income - (IS)	-131M	-14.28M	-229M	-45.44M	-24.76M
Net Income to Common Incl Extra Items	-131M	-14.28M	-229M	-45.44M	-24.76M
Net Income to Common Excl. Extra Items	-131M	-14.28M	-229M	-45.44M	-24.76M
Per Share Items
Net EPS - Basic	-2.04	-0.18	-2.82	-0.48	-0.19
Basic EPS - Continuing Operations	-2.04	-0.18	-2.82	-0.48	-0.19
Basic Weighted Average Shares Outstanding	64.03M	77.23M	81.29M	95.29M	128M
Net EPS - Diluted	-2.04	-0.18	-2.82	-0.48	-0.19
Diluted EPS - Continuing Operations	-2.04	-0.18	-2.82	-0.48	-0.19
Diluted Weighted Average Shares Outstanding	64.03M	77.23M	81.29M	95.29M	128M
Normalized Basic EPS	-0.83	-0.05	-0.33	-0.3	-0.07
Normalized Diluted EPS	-0.83	-0.05	-0.33	-0.3	-0.07
Supplemental Items
EBITDA	-50.92M	-15.06M	-25.37M	-23.95M	762K
EBITA	-80.56M	-36.39M	-45.68M	-32.53M	-10.09M
EBIT	-80.99M	-38.91M	-48.79M	-35.67M	-15.3M
Total Revenues (As Reported)	79.16M	146M	149M	160M	259M
Effective Tax Rate - (Ratio)	-	0.61	1.51	-	35.74
Total Current Taxes	-	400K	-180K	-	-
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	-	-488K	-3.34M	-	-13.77M
Normalized Net Income	-53.13M	-4.1M	-26.42M	-28.83M	-8.86M
Interest on Long-Term Debt	2.96M	429K	301K	252K	554K
Supplemental Operating Expense Items
Selling and Marketing Expenses	15.81M	16.86M	17.86M	19.85M	31.1M
General and Administrative Expenses	33.56M	42.91M	48.95M	45.87M	59.5M
Research And Development Expense From Footnotes	3.45M	5.96M	12.19M	11.2M	10.94M
Stock-Based Comp., SG&A Exp. (Total)	3.22M	4.74M	4.87M	-	-
Stock-Based Comp., Other (Total)	681K	382K	419K	7.18M	4.22M
Total Stock-Based Compensation	3.9M	5.13M	5.29M	7.18M	4.22M

Fiscal Period: September	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	55.36M	68.52M	33.86M	107M	28.2M
Short Term Investments	128M	30.09M	-	821K	826K
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	184M	98.61M	33.86M	108M	29.03M
Accounts Receivable, Total	20.2M	43.86M	27.46M	32.66M	63.58M
Other Receivables	830K	2.51M	2.7M	4.5M	1.27M
Notes Receivable	250K	-	-	-	-
Total Receivables	21.28M	46.37M	30.16M	37.15M	64.86M
Inventory	48.82M	68.28M	80.95M	82.52M	124M
Prepaid Expenses	6.96M	8.36M	11M	9.12M	11.66M
Restricted Cash	-	-	-	25.86M	55.39M
Other Current Assets, Total	-	-	-	-	-
Total Current Assets	261M	222M	156M	262M	285M
Gross Property Plant And Equipment	297M	342M	352M	355M	393M
Accumulated Depreciation	-61.04M	-82.34M	-253M	-259M	-270M
Net Property Plant And Equipment	236M	260M	99.05M	96.23M	123M
Long-term Investments	5.03M	6.29M	13.72M	40.73M	49.55M
Goodwill	14.32M	41.98M	0	0	52.52M
Other Intangibles, Total	2.72M	14.26M	10.62M	8.09M	48.51M
Deferred Charges Long-Term	7K	30K	391K	74K	214K
Other Long-Term Assets, Total	35.38M	33.11M	18.7M	517K	3.54M
Total Assets	554M	577M	298M	408M	562M
Liabilities
Accounts Payable, Total	18.95M	40.86M	20.01M	47.1M	89.25M
Current Portion of Long-Term Debt	80K	80K	76K	60K	25K
Current Portion of Leases	984K	916K	1.01M	1.03M	979K
Current Income Taxes Payable	-	1.42M	94K	-	-
Other Current Liabilities	6.25M	12M	1.24M	5.14M	35.91M
Total Current Liabilities	26.27M	55.28M	22.43M	53.32M	126M
Long-Term Debt	230K	155K	79K	25K	-
Long-Term Leases	4.65M	2.21M	3.55M	3.34M	7.75M
Deferred Tax Liability Non Current	-	3.62M	-	-	-
Other Non Current Liabilities	43.06M	7.79M	771K	14.11M	10.52M
Total Liabilities	74.21M	69.05M	26.83M	70.8M	144M
Preferred Stock Non Redeemable	-	-	-	31.07M	68.65M
Total Preferred Equity	-	-	-	31.07M	68.65M
Common Stock, Total	731M	770M	777M	853M	920M
Retained Earnings	-276M	-290M	-539M	-584M	-609M
Comprehensive Income and Other	24.65M	28.26M	33.24M	37.07M	37.95M
Total Common Equity	480M	508M	272M	306M	349M
Total Equity	480M	508M	272M	337M	418M
Total Liabilities And Equity	554M	577M	298M	408M	562M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	74.96M	78.46M	81.16M	126M	135M
ECS Total Common Shares Outstanding	74.7M	78.45M	81.16M	109M	134M
Book Value / Share	6.42	6.48	3.35	2.82	2.6
Tangible Book Value	463M	452M	261M	298M	248M
Tangible Book Value Per Share	6.2	5.76	3.22	2.74	1.85
Total Debt	5.94M	3.36M	4.72M	4.46M	8.75M
Net Debt	-178M	-95.25M	-29.14M	-103M	-20.27M
Equity Method Investments, Total	5.03M	6.29M	5.28M	-	-
Account Code - Inventory Valuation	3	3	3	3	3
Inventories - Raw Materials, Total	6.02M	9.32M	8.79M	9.36M	17.32M
Inventories - Work In Process, Total	2.69M	2.78M	1.98M	3.62M	7.72M
Inventories - Finished Goods, Total	27.2M	36.54M	50.05M	51.07M	77.41M
Inventories - Others	12.91M	19.64M	20.14M	18.48M	21.5M
Land - (BS)	4.08M	4.7M	4.7M	4.7M	4.7M
Buildings, Total	136M	146M	161M	163M	164M
Machinery, Total	139M	165M	167M	169M	186M
Full Time Employees	693	882	984	898	1.14K
Accumulated Allowance for Doubtful Accounts (Supple)	-	71K	524K	4.7M	4.97M

Fiscal Period: September	2021	2022	2023	2024	2025
Net Income	-131M	-14.28M	-229M	-45.44M	-24.76M
Depreciation & Amortization - CF	30.46M	22.26M	20.97M	8.94M	11.91M
Amortization of Goodwill and Intangible Assets - (CF)	422K	2.52M	3.11M	3.14M	5.21M
Depreciation & Amortization, Total	30.89M	24.78M	24.08M	12.08M	17.12M
Amortization of Deferred Charges, Total - (CF)	950K	131K	90.46K	-	853K
(Gain) Loss From Sale Of Asset	2.43M	6.58M	386K	-633K	9K
(Gain) Loss on Sale of Investments - (CF)	3.27M	-	-	-	-
Asset Writedown & Restructuring Costs	1.7M	4.24M	194M	-	-
Provision for Credit Losses	1.98M	250K	-	-	-
(Income) Loss On Equity Investments - (CF)	1.12M	1.36M	927K	5.28M	-
Stock-Based Compensation (CF)	3.9M	5.13M	5.29M	7.18M	4.22M
Provision and Write-off of Bad Debts	-	-	-	4.22M	274K
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	31.7M	-41.52M	-25.95M	6.22M	-3.18M
Change In Accounts Receivable	-6.01M	-24.02M	12.51M	-12.06M	-15.29M
Change In Inventories	28.68M	-12.22M	-	-	-
Change In Accounts Payable	2.06M	12.15M	-17.6M	27.02M	13.16M
Change In Deferred Taxes	-	-	-	-	-
Change in Other Net Operating Assets	-542K	1.21M	-	-	-
Cash from Operations	-28.59M	-36.21M	-35.8M	3.87M	-7.59M
Capital Expenditure	-11.79M	-48.75M	-26.9M	-4.73M	-17.02M
Sale of Property, Plant, and Equipment	34K	-	948K	257K	112K
Cash Acquisitions	-	-8.44M	-	-	-65.62M
Sale (Purchase) of Intangible assets	-538K	-30K	-1.19M	-607K	-27K
Investment in Marketable and Equity Securities, Total	-72.49M	95.47M	20.15M	-29.24M	-110K
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-
Other Investing Activities, Total	-30.33M	5.78M	11.55M	-4.45M	1.6M
Cash from Investing	-115M	44.03M	4.56M	-38.77M	-81.07M
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Long-Term Debt Repaid, Total	-116M	-1.01M	-837K	-786K	-1.85M
Total Debt Repaid	-116M	-1.01M	-773K	-786K	-1.85M
Issuance of Common Stock	283M	6.43M	36K	109M	41.18M
Other Financing Activities, Total	7.76M	-85K	-17.54K	-	-
Cash from Financing	174M	5.33M	-754K	108M	39.33M
Foreign Exchange Rate Adjustments	-	-	-	-	313K
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	30.76M	13.15M	-31.99M	72.88M	-49.01M
Supplemental Items
Cash Interest Paid	2.4M	-	-	-	-
Levered Free Cash Flow	-1.84M	-60.2M	-	-10.02M	-32.72M
Unlevered Free Cash Flow	6.75K	-59.93M	-	-10.02M	-32.72M
Change In Net Working Capital	-27.22M	16.87M	-	1.65M	28.3M
Net Debt Issued / Repaid	-116M	-1.01M	-773K	-786K	-1.85M

Fiscal Period: September	2021	2022	2023	2024	2025
Profitability
Return on Assets	-10.23	-4.3	-	-6.31	-1.97
Return on Total Capital	-11.2	-4.88	-	-7.22	-2.49
Return On Equity %	-33.54	-2.89	-	-14.93	-6.56
Return on Common Equity	-33.54	-2.89	-	-15.73	-7.56
Margin Analysis
Gross Profit Margin %	-35.87	21.65	23.51	29.73	34.81
SG&A Margin	66.43	44.24	48.04	41.12	34.95
EBITDA Margin %	-64.33	-10.33	-17	-14.98	0.29
EBITA Margin %	-101.77	-24.96	-30.61	-20.35	-3.89
EBIT Margin %	-102.3	-26.68	-32.7	-22.32	-5.9
Income From Continuing Operations Margin %	-165.11	-9.8	-153.8	-28.43	-9.55
Net Income Margin %	-165.11	-9.8	-153.8	-28.43	-9.55
Net Avail. For Common Margin %	-165.11	-9.8	-153.8	-28.43	-9.55
Normalized Net Income Margin	-67.12	-2.81	-17.71	-18.03	-3.42
Levered Free Cash Flow Margin	-2.33	-41.28	-	-6.27	-12.62
Unlevered Free Cash Flow Margin	0.01	-41.1	-	-6.27	-12.62
Asset Turnover
Asset Turnover	0.16	0.26	-	0.45	0.53
Fixed Assets Turnover	0.33	0.59	-	1.64	2.36
Receivables Turnover (Average Receivables)	5.06	4.55	-	5.32	5.39
Inventory Turnover (Average Inventory)	1.78	1.95	-	1.37	1.64
Short Term Liquidity
Current Ratio	9.92	4.01	6.95	4.92	2.26
Quick Ratio	7.79	2.62	2.85	2.71	0.74
Operating Cash Flow to Current Liabilities	-1.09	-0.65	-1.6	0.07	-0.06
Days Sales Outstanding (Average Receivables)	72.13	80.19	-	68.82	67.77
Days Outstanding Inventory (Average Inventory)	204.58	187.07	-	266.36	223.02
Average Days Payable Outstanding	76.24	81.65	-	107.83	118.27
Cash Conversion Cycle (Average Days)	200.47	185.61	-	227.35	172.52
Long Term Solvency
Total Debt/Equity	1.24	0.66	1.74	1.32	2.09
Total Debt / Total Capital	1.22	0.66	1.71	1.3	2.05
LT Debt/Equity	1.02	0.46	1.34	1	1.85
Long-Term Debt / Total Capital	1	0.46	1.31	0.99	1.82
Total Liabilities / Total Assets	13.4	11.96	8.99	17.36	25.69
EBIT / Interest Expense	-27.36	-90.69	-175.6	-	-
EBITDA / Interest Expense	-16.93	-32.94	-88.92	-	-
(EBITDA - Capex) / Interest Expense	-20.91	-146.57	-185.74	-	-
Total Debt / EBITDA	-0.12	-0.24	-0.19	-0.19	4.8
Net Debt / EBITDA	3.55	6.74	1.18	4.37	-11.13
Total Debt / (EBITDA - Capex)	-0.1	-0.05	-0.09	-0.16	-0.58
Net Debt / (EBITDA - Capex)	2.87	1.51	0.56	3.64	1.33
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-8.79	84.19	-	7.13	62.15
Gross Profit, 1 Yr. Growth %	-43.65	-211.16	-	35.5	89.83
EBITDA, 1 Yr. Growth %	-38.24	-70.44	-	-5.58	-103.31
EBITA, 1 Yr. Growth %	-18.99	-54.83	-	-28.78	-68.09
EBIT, 1 Yr. Growth %	-18.72	-51.96	-	-26.89	-55.98
Earnings From Cont. Operations, 1 Yr. Growth %	-4	-89.07	-	-80.2	-45.51
Net Income, 1 Yr. Growth %	-4	-89.07	-	-80.2	-45.51
Normalized Net Income, 1 Yr. Growth %	-19.57	-94.25	-	10.43	-62.18
Diluted EPS Before Extra, 1 Yr. Growth %	-35.32	-90.94	-	-83.1	-59.33
Accounts Receivable, 1 Yr. Growth %	82.31	117.08	-	18.93	94.72
Inventory, 1 Yr. Growth %	-31.97	39.87	-	1.94	50.2
Net Property, Plant and Equip., 1 Yr. Growth %	-4.64	10.12	-	-2.84	27.79
Total Assets, 1 Yr. Growth %	27.32	4.17	-	36.66	37.84
Tangible Book Value, 1 Yr. Growth %	55.42	-2.36	-	14.14	-16.72
Common Equity, 1 Yr. Growth %	60.19	5.89	-	12.65	14.1
Cash From Operations, 1 Yr. Growth %	-36.64	26.66	-	-110.82	-296.05
Capital Expenditures, 1 Yr. Growth %	-84.73	314.63	-	-82.41	259.8
Levered Free Cash Flow, 1 Yr. Growth %	-97.94	3.23K	-	-	246.36
Unlevered Free Cash Flow, 1 Yr. Growth %	-100.01	-147K	-	-	246.36
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-0.78	29.61	-	-	31.8
Gross Profit, 2 Yr. CAGR %	-23.45	-20.85	-	-	60.38
EBITDA, 2 Yr. CAGR %	84.24	-57.27	-	-	-82.67
EBITA, 2 Yr. CAGR %	262.47	-39.51	-	-	-53
EBIT, 2 Yr. CAGR %	264.37	-37.51	-	-	-44
Earnings From Cont. Operations, 2 Yr. CAGR %	270.84	-67.61	-	-	-67.15
Net Income, 2 Yr. CAGR %	270.1	-67.61	-	-	-67.15
Normalized Net Income, 2 Yr. CAGR %	351.68	-75.08	-	-	-41.74
Diluted EPS Before Extra, 2 Yr. CAGR %	175.08	-75.79	-	-	-73.78
Accounts Receivable, 2 Yr. CAGR %	31.8	98.94	-	-	52.18
Inventory, 2 Yr. CAGR %	-34.5	-2.45	-	-	23.74
Net Property, Plant and Equip., 2 Yr. CAGR %	3.92	2.48	-	-	11.43
Total Assets, 2 Yr. CAGR %	13.7	15.16	-	-	37.25
Tangible Book Value, 2 Yr. CAGR %	19.34	23.18	-	-	-2.5
Common Equity, 2 Yr. CAGR %	21.13	30.24	-	-	13.37
Cash From Operations, 2 Yr. CAGR %	-9.73	-10.42	-	-	-53.95
Capital Expenditures, 2 Yr. CAGR %	-67.07	-20.55	-	-	-20.45
Levered Free Cash Flow, 2 Yr. CAGR %	-88.29	-17.99	-	-	-
Unlevered Free Cash Flow, 2 Yr. CAGR %	-99.28	-16.65	-	-	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	85.37	21.94	-	-	-
Gross Profit, 3 Yr. CAGR %	-18.07	-13.32	-	-	-
EBITDA, 3 Yr. CAGR %	8.43	0.12	-	-	-
EBITA, 3 Yr. CAGR %	30.3	81.05	-	-	-
EBIT, 3 Yr. CAGR %	30.53	85.45	-	-	-
Earnings From Cont. Operations, 3 Yr. CAGR %	80.78	14.54	-	-	-
Net Income, 3 Yr. CAGR %	85.39	14.39	-	-	-
Normalized Net Income, 3 Yr. CAGR %	45.19	16.34	-	-	-
Diluted EPS Before Extra, 3 Yr. CAGR %	43.14	-11.82	-	-	-
Accounts Receivable, 3 Yr. CAGR %	194.26	55.65	-	-	-
Inventory, 3 Yr. CAGR %	-9.02	-15.66	-	-	-
Net Property, Plant and Equip., 3 Yr. CAGR %	33.74	5.95	-	-	-
Total Assets, 3 Yr. CAGR %	22.34	10.43	-	-	-
Tangible Book Value, 3 Yr. CAGR %	35.85	11.62	-	-	-
Common Equity, 3 Yr. CAGR %	37.49	15.82	-	-	-
Cash From Operations, 3 Yr. CAGR %	31.04	1.06	-	-	-
Capital Expenditures, 3 Yr. CAGR %	-40.66	-23.47	-	-	-
Levered Free Cash Flow, 3 Yr. CAGR %	-72.57	-23.49	-	-	-
Unlevered Free Cash Flow, 3 Yr. CAGR %	-95.67	-22.42	-	-	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	66.82	93.4	-	-	-
Gross Profit, 5 Yr. CAGR %	39.82	57.12	-	-	-
EBITDA, 5 Yr. CAGR %	90.47	9.54	-	-	-
EBITA, 5 Yr. CAGR %	130.22	26.8	-	-	-
EBIT, 5 Yr. CAGR %	130.46	28.51	-	-	-
Earnings From Cont. Operations, 5 Yr. CAGR %	173.98	5.72	-	-	-
Net Income, 5 Yr. CAGR %	173.98	5.58	-	-	-
Normalized Net Income, 5 Yr. CAGR %	151.39	-9.51	-	-	-
Diluted EPS Before Extra, 5 Yr. CAGR %	104.05	-16.1	-	-	-
Accounts Receivable, 5 Yr. CAGR %	83.65	145.68	-	-	-
Inventory, 5 Yr. CAGR %	50.57	66.07	-	-	-
Net Property, Plant and Equip., 5 Yr. CAGR %	77.97	41.78	-	-	-
Total Assets, 5 Yr. CAGR %	59.38	44.12	-	-	-
Tangible Book Value, 5 Yr. CAGR %	59.91	41.13	-	-	-
Common Equity, 5 Yr. CAGR %	61.07	43.66	-	-	-
Cash From Operations, 5 Yr. CAGR %	74.4	31.33	-	-	-
Capital Expenditures, 5 Yr. CAGR %	21.69	9.35	-	-	-
Levered Free Cash Flow, 5 Yr. CAGR %	-23.27	12.74	-	-	-
Unlevered Free Cash Flow, 5 Yr. CAGR %	-74.82	12.75	-	-	-